A cigarette burns tobacco at roughly 900 °C and makes thousands of chemicals, including the tar, carbon monoxide, and carcinogens that cause the disease. A vape heats a nicotine liquid at about a fifth of that temperature and makes a fog you breathe in. No combustion, so almost none of the worst stuff 1. What stays: nicotine, which is addictive and raises heart rate, plus trace coil metals and flavour molecules nobody studied as things to inhale. So it isn't safe. It's far less of the worst, plus some new unknowns.
On quitting, the answer is settled. A nicotine vape beats the patches, gum, and lozenges the pharmacy sells, by a wide margin, and lands in the same bracket as prescription quit drugs 2. In the anchor trial, verified quit rates at a year were 18% for vapers versus 9.9% on nicotine replacement 3. Within weeks of fully switching, the lung-cancer-relevant tobacco chemicals in your urine fall toward never-smoker levels 4.
On long-term body harm, the answer is unwritten. Heart rate and airway irritation tick up, but far less than smoking 5. The modern vape is from 2007, so nobody has a thirty-year cohort yet.
Who it's for. If you smoke and want out, the trade is firmly in your favour: full switch, and the vape is the bridge 6. If you've never smoked, none of that benefit exists — you'd be buying the unknown cost against nothing. Don't start 7.
To quit cigarettes with a vape:
What full switching gives back.
- First week: taste and smell return; your clothes stop carrying the smell.
- A month or two: the morning cough fades and stairs stop being a workout.
- A year: exercise tolerance rebuilds and cardiovascular risk starts bending back toward baseline.
- A decade: most of the years cigarettes were going to take are back on the table, if you stay switched. The asterisk that never leaves: you're still on nicotine.
The fine print — when to skip it, and what people get wrong
"As harmful as cigarettes": six in ten believe this; the biomarkers say otherwise 4. "Popcorn lung": real disease, never documented from vaping. "EVALI": traced to vitamin E acetate in illicit THC carts, not nicotine vapes 8.
Skip if pregnant — nicotine in any form harms fetal development; ask a midwife. With unstable heart disease, prescription quit drugs are the safer route.
Dual use keeps the biomarkers near a smoker's. And four in five successful quitters were still vaping a year on — coming off the vape is a second, harder project.
- 1Goniewicz ML, Knysak J, Gawron M et al. (2014). Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobacco Control. link
- 2Hartmann-Boyce J, Lindson N, Butler AR et al. (2024). Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews. link
- 3Hajek P, Phillips-Waller A, Przulj D et al. (2019). A randomized trial of e-cigarettes versus nicotine-replacement therapy. New England Journal of Medicine. link
- 4Goniewicz ML, Smith DM, Edwards KC et al. (2018). Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Network Open. link
- 5Banks E, Yazidjoglou A, Brown S et al. (2023). Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. Medical Journal of Australia. link
- 6Royal College of Physicians (2016). Nicotine without smoke: tobacco harm reduction. link
- 7U.S. Department of Health and Human Services (2016). E-cigarette use among youth and young adults: a report of the Surgeon General. link
- 8Blount BC, Karwowski MP, Shields PG et al. (2020). Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. New England Journal of Medicine. link
დაკავშირებული სახელმძღვანელოში (4)
- — If lung disease is already on the table, getting off cigarettes is the move; a vape can be the bridge.
- — The aerosol dries the mouth and irritates the gums. It's gentler than smoke, but it isn't nothing for your gum line.
- — For a smoker who can't quit other ways, switching fully to a vape captures most of the years cigarettes were taking.
- — Nicotine is a fast, engineered hit on the same reward system feeds exploit; vaping is one of its delivery vehicles.
Vaping (E-Cigarettes)
Minor daily friction — keeping a device charged and topped up; cessation-titration adds an active ~12-week protocol layer for the smoker using vaping as a quit aid.
Heavy disposable use runs $30–80/month ($360–960/year); refillable systems amortise to ~$15–25/month after device cost. Cheaper than cigarettes in high-tax jurisdictions, comparable in the U.S.
Cochrane 2024 reaches high-certainty evidence for cessation efficacy vs. NRT (88 trials, ~27,000 participants); biomarker-exposure reductions vs. cigarettes are consistent and measured (Goniewicz et al. 2018). Long-term incident-disease cohorts do not yet exist — the 15+ year question is genuinely unknown.
Full switchers report morning-cough resolution within ~2–4 weeks, restored taste/smell within days, and exercise tolerance lift within ~4–8 weeks; NNAL and acrolein metabolites approach never-smoker levels at one month (Goniewicz et al. 2018).
For lifetime smokers, full substitution captures most of the ~10-year life-expectancy gain of cessation; Cochrane 2024 high-certainty evidence places EC + nicotine ahead of NRT (RR 1.59) (Hartmann-Boyce et al. 2024, Hajek et al. 2019). Zero longevity effect — and a small negative — in never-smokers.
For smokers who fully substitute, the chronic combustion-vasoconstriction-and-tar-staining trajectory halts; long-term facial-aging delta vs. continued smoking is real but mediated through cessation, not vaping per se.
Acute nicotine alertness effect plus, in ex-smokers, gradual restoration of exercise capacity once combustion exposure ceases. Modest and largely substitution-mediated.
Inhaled nicotine produces a documented acute attentional / reaction-time lift; chronic effect is largely withdrawal-relief rather than a true baseline shift over a nicotine-naive user.
Acute nicotine produces a small calming/lift effect via nAChR-mediated dopamine release; in chronic users this is largely withdrawal management rather than a true baseline shift.